| PFS | ||
---|---|---|---|
HR | 95% CI | p-value | |
Univariate | |||
 Age | 1.13 | 0.59–2.18 | 0.71 |
 Gender | 0.84 | 0.40–1.73 | 0.63 |
 Smoking | 0.73 | 0.38–1.40 | 0.35 |
 Grade | 1.04 | 0.51–2.10 | 0.92 |
 T.size | 1.62 | 0.78–3.35 | 0.19 |
 Laterality | 1.29 | 0.93–1.79 | 0.13 |
 LN metastasis | 1.65 | 1.17–2.34 | 0.005** |
 EGFR mutation | 1.99 | 1.37–2.93 | < 0.001*** |
 ROS1 | 0.95 | 0.61–1.47 | 0.81 |
 ALK | 1.46 | 1.03–2.07 | 0.03* |
 PD-1 | 1.36 | 0.81–2.29 | 0.24 |
 PD-L1 | 1.20 | 0.84–1.73 | 0.31 |
 ROS1 rearrangement | 1.09 | 0.70–1.69 | 0.70 |
Multivariate | |||
 Laterality |  |  |  |
 LN metastasis | 1.59 | 1.11–2.25 | 0.010* |
 ALK | 1.46 | 1.03–2.08 | 0.04* |
 EGFR | 2.08 | 1.37–3.15 | < 0.001*** |